Neumentum is a neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.
Neumentum has raised $16.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2021.
Neumentum's investors include Evolution VC Partners, AngelMD.
Neumentum is headquartered in Morristown, United States.
Neumentum is a neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.
Neumentum is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neumentum — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/neumentum. Accessed August 13, 2026.
VCBacked. (2021). Neumentum — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/neumentum
{{cite web |title=Neumentum — Funding & Investors |url=https://www.vcbacked.co/company/neumentum |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated